Abstract
Introduction:
We report a two centre experience with a depopulated ureteric xenograft (SGVG 100), CryoLife Inc., GA, USA) for femoropopliteal revascularization in 12 patients with chronic critical limb ischemia.
Report:
Between 7 days and 18 months after implantation, 10 of 12 patients (1 lost to follow-up) had the graft explanted due to aneurysmal enlargement. At 5 years, only one graft was still patent and showed moderate signs of enlargement.
Conclusion:
The SGVG 100 is not a safe conduit for femoropopliteal bypass surgery.
MeSH terms
-
Angiography
-
Animals
-
Arterial Occlusive Diseases / complications
-
Arterial Occlusive Diseases / diagnosis
-
Arterial Occlusive Diseases / surgery*
-
Blood Vessel Prosthesis Implantation / instrumentation*
-
Cattle
-
Femoral Artery / diagnostic imaging
-
Femoral Artery / surgery*
-
Follow-Up Studies
-
Humans
-
Ischemia / diagnosis
-
Ischemia / etiology
-
Ischemia / surgery*
-
Leg / blood supply*
-
Popliteal Artery / diagnostic imaging
-
Popliteal Artery / surgery*
-
Prosthesis Design
-
Retrospective Studies
-
Time Factors
-
Transplantation, Heterologous
-
Treatment Outcome
-
Ultrasonography, Doppler, Color
-
Ureter / transplantation*